Advances in the treatment of intrahepatic cholangiocarcinoma: An overview of the current and future therapeutic landscape for clinicians
Intrahepatic cholangiocarcinoma (ICC) is the second most common primary liver tumor and
remains a fatal malignancy in the majority of patients. Approximately 20%–30% of patients …
remains a fatal malignancy in the majority of patients. Approximately 20%–30% of patients …
Cholangiocarcinoma—evolving concepts and therapeutic strategies
SI Ilyas, SA Khan, CL Hallemeier, RK Kelley… - Nature reviews Clinical …, 2018 - nature.com
Cholangiocarcinoma is a disease entity comprising diverse epithelial tumours with features
of cholangiocyte differentiation: cholangiocarcinomas are categorized according to …
of cholangiocyte differentiation: cholangiocarcinomas are categorized according to …
RNA N6‐methyladenosine methyltransferase‐like 3 promotes liver cancer progression through YTHDF2‐dependent posttranscriptional silencing of SOCS2
Epigenetic alterations have contributed greatly to human carcinogenesis. Conventional
epigenetic studies have predominantly focused on DNA methylation, histone modifications …
epigenetic studies have predominantly focused on DNA methylation, histone modifications …
Cholangiocarcinoma
Cholangiocarcinoma represents a diverse group of epithelial cancers united by late
diagnosis and poor outcomes. Specific diagnostic and therapeutic approaches are …
diagnosis and poor outcomes. Specific diagnostic and therapeutic approaches are …
[HTML][HTML] Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma
Cholangiocarcinoma (CCA) comprises a heterogeneous group of cancers with pathologic
features of biliary tract differentiation, and is presumed to arise from the intra-or extrahepatic …
features of biliary tract differentiation, and is presumed to arise from the intra-or extrahepatic …
Pathogenesis, diagnosis, and management of cholangiocarcinoma
SI Ilyas, GJ Gores - Gastroenterology, 2013 - Elsevier
Cholangiocarcinomas (CCAs) are hepatobiliary cancers with features of cholangiocyte
differentiation; they can be classified anatomically as intrahepatic CCA (iCCA), perihilar …
differentiation; they can be classified anatomically as intrahepatic CCA (iCCA), perihilar …
New horizons for precision medicine in biliary tract cancers
Biliary tract cancers (BTC), including cholangiocarcinoma and gallbladder cancer, are poor-
prognosis and low-incidence cancers, although the incidence of intrahepatic …
prognosis and low-incidence cancers, although the incidence of intrahepatic …
Prognostic nomogram for intrahepatic cholangiocarcinoma after partial hepatectomy
Y Wang, J Li, Y **a, R Gong, K Wang, Z Yan… - Journal of clinical …, 2013 - ascopubs.org
Purpose This study aimed to establish an effective prognostic nomogram for intrahepatic
cholangiocarcinoma (ICC) after partial hepatectomy. Patients and Methods The nomogram …
cholangiocarcinoma (ICC) after partial hepatectomy. Patients and Methods The nomogram …
Cholangiocarcinoma: current knowledge and new developments
B Blechacz - Gut and liver, 2016 - pmc.ncbi.nlm.nih.gov
Cholangiocarcinoma (CCA) is the second most common primary malignancy. Although it is
more common in Asia, its incidence in Europe and North America has significantly increased …
more common in Asia, its incidence in Europe and North America has significantly increased …
Treatment and prognosis for patients with intrahepatic cholangiocarcinoma: systematic review and meta-analysis
Importance Data on outcomes following surgical management of intrahepatic
cholangiocarcinoma (ICC) are limited. The incidence of ICC is increasing and it has a poor …
cholangiocarcinoma (ICC) are limited. The incidence of ICC is increasing and it has a poor …